PUBLISHER: The Business Research Company | PRODUCT CODE: 1668680
PUBLISHER: The Business Research Company | PRODUCT CODE: 1668680
Vitrectomy devices are specialized surgical instruments utilized for the performance of vitrectomy procedures, which involve the removal of the vitreous gel from the eye. This surgical intervention is crucial in treating various eye conditions such as retinal detachments and vitreous hemorrhages. The vitreous gel, a transparent, jelly-such as substance situated between the lens and the retina in the eye, is targeted during vitrectomy.
The primary product types in the realm of vitrectomy devices include vitrectomy machines, vitrectomy packs, photocoagulation lasers, and illumination devices. Vitrectomy machines, serving as essential surgical equipment, typically consist of a console that manages the cutting, suction, and illumination functions of the surgical instruments. Various surgical approaches, such as posterior or pars plana vitrectomy and anterior vitrectomy, find application in addressing conditions such as diabetic retinopathy, retinal detachment, macular hole, vitreous hemorrhage, among others.
The vitrectomy devices market research report is one of a series of new reports from The Business Research Company that provides vitrectomy devices market statistics, including vitrectomy devices industry global market size, regional shares, competitors with a vitrectomy devices market share, detailed vitrectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the vitrectomy devices industry. This vitrectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vitrectomy devices market size has grown strongly in recent years. It will grow from$1.66 billion in 2024 to $1.75 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to early challenges in adoption, clinical research and evidence, limited treatment options, manual control and precision, early adoption in specialized cases
The vitrectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to focus on value-based healthcare, demand for cost-effective solutions, patient preference for advanced treatments, regulatory support and approvals, market penetration in emerging economies. Major trends in the forecast period include miniaturization & portability, integration of advanced imaging, enhanced surgical visualization, growth in minimally invasive procedures, customization and personalization.
The anticipated growth in the vitrectomy device market is expected to be propelled by the increasing prevalence of visual impairment. Visual impairment is a condition that hampers a person's ability to see, impacting their daily activities. This rise is largely attributed to factors such as the aging population, the surge in chronic diseases, and unhealthy lifestyles. Vitrectomy devices play a crucial role in treating various eye conditions associated with visual impairment. As of October 2022, the World Health Organization (WHO), a United Nations Agency, reported that approximately 2.2 billion people globally experience near or distant vision impairment, with almost half of these cases (around 1 billion) being either preventable or unaddressed. Hence, the growing prevalence of visual impairment is expected to drive the growth of the vitrectomy devices market.
The rising prevalence of diabetes is anticipated to drive the growth of the vitrectomy devices market in the coming years. Diabetes is a chronic condition characterized by elevated blood glucose levels, often due to the body's inability to produce or effectively use insulin. Vitrectomy is a surgical procedure frequently employed to treat advanced stages of diabetic retinopathy, especially when there is bleeding in the vitreous humor or scar tissue formation affecting vision. The increasing number of diabetes cases expands the patient population needing vitrectomy procedures, thereby boosting the demand for vitrectomy devices. For example, in June 2024, the National Health Service (NHS), a UK-based publicly funded healthcare system, reported that 3,615,330 people registered with a GP were diagnosed with non-diabetic hyperglycemia, or pre-diabetes, in 2023, up from 3,065,825 in 2022-an increase of nearly 18%. Consequently, the growing prevalence of diabetes is propelling the growth of the vitrectomy devices market.
Major companies in the vitrectomy devices market are concentrating on developing advanced products, including innovative surgical systems that enhance precision and efficiency in eye surgeries. These cutting-edge surgical systems are designed to improve visualization and control during vitreoretinal procedures, ultimately resulting in better patient outcomes. For example, in September 2024, Alcon, a Switzerland-based provider of eye care solutions, launched its latest digital innovations: SmartCataract DX and NGENUITY 1.5. SmartCataract DX offers real-time data analytics during cataract surgery, while NGENUITY 1.5 enhances visualization with high-definition capabilities.
Leading companies in the vitrectomy devices market are also investing in the development of ophthalmic surgery systems to gain a competitive edge. Ophthalmic surgery systems are comprehensive platforms tailored for various eye-related procedures, including those related to the retina and cataracts. Dutch Ophthalmic Research Center International B.V., for instance, launched the EVA NEXUS in March 2022, an ophthalmic surgery system resulting from global collaborations with surgeons. EVA NEXUS incorporates SmartIOP technology for precise control in cataract surgery, EquiPhaco enhancements to optimize phaco energy efficiency, and Eva Inicio, the first approved micro-injection system for sub-1ml injections. The Eva Aveta trocar cannula system within EVA NEXUS ensures enhanced performance, and the system's versatility allows independent irrigation and infusion lines for both anterior and posterior surgery. With ergonomic enhancements, active monitoring capabilities, and advanced technological integration, Eva Nexus has demonstrated its effectiveness in over 400 vitrectomy and 1500 cataract surgeries during limited release.
In October 2022, Dutch Ophthalmic Research Center (DORC) acquired Peregrine Surgical LLC, a US-based surgical instrument manufacturer, for an undisclosed amount. This acquisition positions DORC to offer a more comprehensive range of surgical instruments, enhancing its ability to provide high-quality products and services to ophthalmic surgeons and their patients, particularly in the US ophthalmic market.
Major companies operating in the vitrectomy devices market include Alcon Inc., Bausch and Lomb Incorporated, Beaver-Visitec International Holdings Inc., Nidek Co. Ltd., Johnson and Johnson Vision Care Inc., Blink Medical Limited, Topcon Corporation, HOYA Medical Singapore Pte Ltd., Carl Zeiss Meditec AG, Optos plc, IRIDEX Corporation, Dutch Ophthalmic Research Center, Danaher Corporation, Lumenis Ltd., Synergetics Inc., Advanced Optisurgical Inc., OCULUS Optikgerate GmbH, MedOne Surgical Inc., Designs for Vision Inc., Geuder AG, Ellex Medical Lasers Ltd., Erbe Elektromedizin GmbH, Halma plc, Ophthalmic Instruments Inc., Accutome Inc., Rhein Medical Inc., FCI Ophthalmics Inc., Insight Instruments Corp., Rumex International Corporation, Oertli Instrumente AG
North America was the largest region in the vitrectomy devices market in 2024. Asia-pacific is expected to be the fastest-growing region in the global vitrectomy devices market report during the forecast period. The regions covered in the vitrectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the vitrectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vitrectomy devices market consists of sales of vitrectomy machines, vitreous cutters, forceps, scissors, micro vitreo retinal (MVR) blade and illumination probes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vitrectomy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vitrectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vitrectomy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vitrectomy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.